201 related articles for article (PubMed ID: 24885030)
1. Recombinant tandem multi-linear neutralizing epitopes of human enterovirus 71 elicited protective immunity in mice.
Li YX; Zhao H; Cao RY; Deng YQ; Han JF; Zhu SY; Ma J; Liu L; Qin ED; Qin CF
Virol J; 2014 May; 11():79. PubMed ID: 24885030
[TBL] [Abstract][Full Text] [Related]
2. Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon.
Tian X; Su X; Li X; Li H; Li T; Zhou Z; Zhong T; Zhou R
PLoS One; 2012; 7(7):e41381. PubMed ID: 22848478
[TBL] [Abstract][Full Text] [Related]
3. Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge.
Zhang F; Hao C; Zhang S; Li A; Zhang Q; Wu W; Liu L; Li C; Liang M; Li X; Li D
Virol J; 2014 May; 11():80. PubMed ID: 24885121
[TBL] [Abstract][Full Text] [Related]
4. Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop.
Xu L; He D; Li Z; Zheng J; Yang L; Yu M; Yu H; Chen Y; Que Y; Shih JW; Liu G; Zhang J; Zhao Q; Cheng T; Xia N
Theranostics; 2014; 4(5):498-513. PubMed ID: 24669278
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice.
Huo C; Yang J; Lei L; Qiao L; Xin J; Pan Z
Vaccine; 2017 Dec; 35(52):7322-7330. PubMed ID: 29129453
[TBL] [Abstract][Full Text] [Related]
6. Induction of protective immune responses against EV71 in mice by baculovirus encoding a novel expression cassette for capsid protein VP1.
Premanand B; Kiener TK; Meng T; Tan YR; Jia Q; Chow VT; Kwang J
Antiviral Res; 2012 Sep; 95(3):311-5. PubMed ID: 22691220
[TBL] [Abstract][Full Text] [Related]
7. The C Terminus of the Core β-Ladder Domain in Japanese Encephalitis Virus Nonstructural Protein 1 Is Flexible for Accommodation of Heterologous Epitope Fusion.
Yen LC; Liao JT; Lee HJ; Chou WY; Chen CW; Lin YL; Liao CL
J Virol; 2016 Feb; 90(3):1178-89. PubMed ID: 26559836
[TBL] [Abstract][Full Text] [Related]
8. Pros and cons of VP1-specific maternal IgG for the protection of Enterovirus 71 infection.
Kim YI; Song JH; Kwon BE; Kim HN; Seo MD; Park K; Lee S; Yeo SG; Kweon MN; Ko HJ; Chang SY
Vaccine; 2015 Nov; 33(48):6604-10. PubMed ID: 26529069
[TBL] [Abstract][Full Text] [Related]
9. Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide.
Foo DG; Alonso S; Chow VT; Poh CL
Microbes Infect; 2007 Sep; 9(11):1299-306. PubMed ID: 17890123
[TBL] [Abstract][Full Text] [Related]
10. Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms.
Ye X; Ku Z; Liu Q; Wang X; Shi J; Zhang Y; Kong L; Cong Y; Huang Z
J Virol; 2014 Jan; 88(1):72-81. PubMed ID: 24131712
[TBL] [Abstract][Full Text] [Related]
11. Display of enterovirus 71 VP1 on baculovirus as a type II transmembrane protein elicits protective B and T cell responses in immunized mice.
Kolpe AB; Kiener TK; Grotenbreg GM; Kwang J
Virus Res; 2012 Sep; 168(1-2):64-72. PubMed ID: 22728446
[TBL] [Abstract][Full Text] [Related]
12. VP1 of Enterovirus 71 Protects Mice Against Enterovirus 71 and Coxsackievirus B3 in Lethal Challenge Experiment.
Chen FH; Liu X; Fang HL; Nan N; Li Z; Ning NZ; Luo DY; Li T; Wang H
Front Immunol; 2019; 10():2564. PubMed ID: 31787970
[TBL] [Abstract][Full Text] [Related]
13. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon.
Xue C; Tian X; Li X; Zhou Z; Su X; Zhou R
Virus Res; 2014 Apr; 183():67-74. PubMed ID: 24518297
[TBL] [Abstract][Full Text] [Related]
14. Immunization of N terminus of enterovirus 71 VP4 elicits cross-protective antibody responses.
Zhao M; Bai Y; Liu W; Xiao X; Huang Y; Cen S; Chan PK; Sun X; Sheng W; Zeng Y
BMC Microbiol; 2013 Dec; 13():287. PubMed ID: 24320792
[TBL] [Abstract][Full Text] [Related]
15. Partial protection against enterovirus 71 (EV71) infection in a mouse model immunized with recombinant Newcastle disease virus capsids displaying the EV71 VP1 fragment.
Ch'ng WC; Stanbridge EJ; Ong KC; Wong KT; Yusoff K; Shafee N
J Med Virol; 2011 Oct; 83(10):1783-91. PubMed ID: 21837796
[TBL] [Abstract][Full Text] [Related]
16. A new EV71 VP3 epitope in norovirus P particle vector displays neutralizing activity and protection in vivo in mice.
Jiang L; Fan R; Sun S; Fan P; Su W; Zhou Y; Gao F; Xu F; Kong W; Jiang C
Vaccine; 2015 Nov; 33(48):6596-603. PubMed ID: 26529072
[TBL] [Abstract][Full Text] [Related]
17. Immunization with a fusion protein vaccine candidate generated from truncated peptides of human enterovirus 71 protects mice from lethal enterovirus 71 infections.
Liu J; Zhao B; Xue L; Wu J; Xu Y; Liu Y; Qin C
Virol J; 2020 Apr; 17(1):58. PubMed ID: 32321526
[TBL] [Abstract][Full Text] [Related]
18. A Broadly Cross-protective Vaccine Presenting the Neighboring Epitopes within the VP1 GH Loop and VP2 EF Loop of Enterovirus 71.
Xu L; He D; Yang L; Li Z; Ye X; Yu H; Zhao H; Li S; Yuan L; Qian H; Que Y; Kuo Shih JW; Zhu H; Li Y; Cheng T; Xia N
Sci Rep; 2015 Aug; 5():12973. PubMed ID: 26243660
[TBL] [Abstract][Full Text] [Related]
19. EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge.
Wang X; Xiao X; Zhao M; Liu W; Pang L; Sun X; Cen S; Yang BB; Huang Y; Sheng W; Zeng Y
BMC Res Notes; 2016 Jan; 9():42. PubMed ID: 26809443
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the enterovirus 71 P1 polyprotein expressed in Pichia pastor as a candidate vaccine.
Han X; Ying XL; Zhou SL; Han T; Huang H; Jin Q; Yang F; Sun QY; Sun XX
Hum Vaccin Immunother; 2014; 10(8):2220-6. PubMed ID: 25424925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
